Max Taubert

653 total citations
42 papers, 478 citations indexed

About

Max Taubert is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Max Taubert has authored 42 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 8 papers in Pediatrics, Perinatology and Child Health and 8 papers in Pharmacology. Recurrent topics in Max Taubert's work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Drug Transport and Resistance Mechanisms (5 papers). Max Taubert is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (17 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Drug Transport and Resistance Mechanisms (5 papers). Max Taubert collaborates with scholars based in Germany, China and Austria. Max Taubert's co-authors include Uwe Fuhr, Michael Zöller, Michael Vogeser, Christina Scharf, Sebastian Frechen, Johannes Zander, Lorenz Frey, Martin H. J. Wiesen, Uwe Liebchen and Xia Li and has published in prestigious journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and Clinical Pharmacology & Therapeutics.

In The Last Decade

Max Taubert

38 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max Taubert Germany 13 207 93 87 71 66 42 478
María Victoria Martínez Calvo Spain 14 299 1.4× 144 1.5× 147 1.7× 52 0.7× 27 0.4× 44 620
Susan Raber United States 14 283 1.4× 168 1.8× 132 1.5× 99 1.4× 21 0.3× 33 628
Loretta Franceschi Italy 11 194 0.9× 88 0.9× 151 1.7× 35 0.5× 35 0.5× 19 509
Michel Lavit France 14 186 0.9× 133 1.4× 95 1.1× 71 1.0× 34 0.5× 36 643
Hidetoshi Furuie Japan 13 127 0.6× 120 1.3× 37 0.4× 97 1.4× 129 2.0× 32 635
Nao Kawaguchi Japan 13 128 0.6× 180 1.9× 86 1.0× 113 1.6× 15 0.2× 27 470
Yi Zheng China 14 271 1.3× 154 1.7× 91 1.0× 62 0.9× 34 0.5× 65 630
Dawn Harper United States 8 115 0.6× 44 0.5× 78 0.9× 113 1.6× 49 0.7× 9 375
Steven J. Kovacs United States 12 70 0.3× 63 0.7× 57 0.7× 62 0.9× 129 2.0× 19 469
Nynke G L Jager Netherlands 15 266 1.3× 91 1.0× 63 0.7× 57 0.8× 92 1.4× 38 719

Countries citing papers authored by Max Taubert

Since Specialization
Citations

This map shows the geographic impact of Max Taubert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Taubert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Taubert more than expected).

Fields of papers citing papers by Max Taubert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Taubert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Taubert. The network helps show where Max Taubert may publish in the future.

Co-authorship network of co-authors of Max Taubert

This figure shows the co-authorship network connecting the top 25 collaborators of Max Taubert. A scholar is included among the top collaborators of Max Taubert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Taubert. Max Taubert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Zhendong, et al.. (2025). Validating Low‐Dose Iohexol as a Marker for Glomerular Filtration Rate by In Vitro and In Vivo Studies. Clinical and Translational Science. 18(2). e70141–e70141.
2.
Chen, Chunli, Max Taubert, Martina Kinzig, et al.. (2024). Understanding adefovir pharmacokinetics as a component of a transporter phenotyping cocktail. European Journal of Clinical Pharmacology. 80(7). 1069–1078.
3.
Chen, Zhendong, Max Taubert, Chunli Chen, et al.. (2024). A Semi-Mechanistic Population Pharmacokinetic Model of Noscapine in Healthy Subjects Considering Hepatic First-Pass Extraction and CYP2C9 Genotypes. Drugs in R&D. 24(2). 187–199. 1 indexed citations
4.
5.
Fuhr, Uwe, et al.. (2023). Improved correction formulas to estimate iohexol clearance from simple models. European Journal of Clinical Pharmacology. 79(9). 1215–1217. 2 indexed citations
6.
Chen, Zhendong, Max Taubert, Chunli Chen, et al.. (2023). Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Vancomycin in Patients with External Ventricular Drain. Antimicrobial Agents and Chemotherapy. 67(6). e0024123–e0024123. 5 indexed citations
7.
Fuhr, Uwe, Martin Wiesholzer, Manuel Kussmann, et al.. (2023). Population pharmacokinetics of meropenem in patients undergoing automated peritoneal dialysis. Peritoneal Dialysis International. 43(5). 402–410.
8.
Zöller, Michael, Uwe Fuhr, Ulrich Jaehde, et al.. (2023). Cefepime Population Pharmacokinetics, Antibacterial Target Attainment, and Estimated Probability of Neurotoxicity in Critically Ill Patients. Antimicrobial Agents and Chemotherapy. 67(7). e0030923–e0030923. 8 indexed citations
9.
Chen, Zhendong, Chunli Chen, Max Taubert, Michael Mayersohn, & Uwe Fuhr. (2022). A population pharmacokinetic model for creatinine with and without ingestion of a cooked meat meal. European Journal of Clinical Pharmacology. 78(12). 1945–1947. 1 indexed citations
10.
Taubert, Max, Elke Schäeffner, Peter Martus, et al.. (2021). Advancement of pharmacokinetic models of iohexol in patients aged 70 years or older with impaired kidney function. Scientific Reports. 11(1). 22656–22656. 2 indexed citations
11.
Fuhr, Uwe, et al.. (2021). Clinical Pharmacokinetics and Pharmacodynamics of Cefiderocol. Clinical Pharmacokinetics. 60(12). 1495–1508. 23 indexed citations
12.
Scharf, Christina, Uwe Liebchen, Michael Paal, et al.. (2020). The higher the better? Defining the optimal beta-lactam target for critically ill patients to reach infection resolution and improve outcome. Journal of Intensive Care. 8(1). 86–86. 46 indexed citations
13.
Li, Xia, Max Taubert, Sebastian Frechen, et al.. (2020). A Novel Study Design Using Continuous Intravenous and Intraduodenal Infusions of Midazolam and Voriconazole for Mechanistic Quantitative Assessment of Hepatic and Intestinal CYP3A Inhibition. The Journal of Clinical Pharmacology. 60(9). 1237–1253. 5 indexed citations
14.
Li, Xia, Sebastian Frechen, Thorsten Lehr, et al.. (2019). A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug–Drug Interactions. Clinical Pharmacokinetics. 59(6). 781–808. 46 indexed citations
15.
Scherf‐Clavel, Oliver, Elke Schaeffeler, Max Taubert, et al.. (2019). A Clinical Drug‐Drug Interaction Study Assessing a Novel Drug Transporter Phenotyping Cocktail With Adefovir, Sitagliptin, Metformin, Pitavastatin, and Digoxin. Clinical Pharmacology & Therapeutics. 106(6). 1398–1407. 28 indexed citations
16.
Matzneller, Peter, et al.. (2019). A population pharmacokinetic model of intravenous telavancin in healthy individuals to assess tissue exposure. Naunyn-Schmiedeberg s Archives of Pharmacology. 392(9). 1097–1106. 5 indexed citations
17.
Wiesen, Martin H. J., et al.. (2018). Residual rivaroxaban exposure after discontinuation of anticoagulant therapy in patients undergoing cardiac catheterization. European Journal of Clinical Pharmacology. 74(5). 611–618. 4 indexed citations
18.
Taubert, Max, Natalie Ebert, Peter Martus, et al.. (2018). Using a three-compartment model improves the estimation of iohexol clearance to assess glomerular filtration rate. Scientific Reports. 8(1). 17723–17723. 17 indexed citations
19.
Taubert, Max, Johannes Zander, Sebastian Frechen, et al.. (2017). Optimization of linezolid therapy in the critically ill: the effect of adjusted infusion regimens. Journal of Antimicrobial Chemotherapy. 72(8). 2304–2310. 26 indexed citations
20.
Taubert, Max, Michael Zöller, Bárbara Maier, et al.. (2016). Predictors of Inadequate Linezolid Concentrations after Standard Dosing in Critically Ill Patients. Antimicrobial Agents and Chemotherapy. 60(9). 5254–5261. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Victoria Martínez Calvo Breakdown of academic impact, for papers by Susan Raber Breakdown of academic impact, for papers by Loretta Franceschi Breakdown of academic impact, for papers by Michel Lavit Breakdown of academic impact, for papers by Hidetoshi Furuie Breakdown of academic impact, for papers by Nao Kawaguchi Breakdown of academic impact, for papers by Yi Zheng Breakdown of academic impact, for papers by Dawn Harper Breakdown of academic impact, for papers by Steven J. Kovacs Breakdown of academic impact, for papers by Nynke G L Jager
Rankless by CCL
2026